Former President, Chief Medical Officer · Coya Therapeutics, Inc. (COYA)

Adrian Hepner

A named executive officer of Coya Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$622,158

Salary $285,208Stock awards $0

FY2022: $726,453

3rd of 4 named executive officers at Coya Therapeutics by FY2023 total.

4 named officers on file for Coya Therapeutics, FY2023

Adrian Hepner’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Coya Therapeutics’s whole pay program stands against its peers

  • Coya Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on COYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 28, 2024 (DEF 14A).

Free

Get Adrian Hepner’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Adrian Hepner compensation by year

Coya Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Coya Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$70,833$424,999$285,208
Bonus$0$194,792$0
Stock awards$0$0$0
Option awards$56,018$106,662$336,950
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$0$0$0
Total$126,851$726,453$622,158

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Coya Therapeutics, Inc. DEF 14A filed March 28, 2024, accession 0000950170-24-038090, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Coya Therapeutics, Inc. filed document, accession 0000950170-24-038090. Every figure is read from that document and cited to the page and table it appears in. Filed March 28, 2024.

$127K
$726K
$622K
FY21
FY22
FY23
SalaryBonusOption awards

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option21,947—$3.48
Option83,056—$3.85

Per the Outstanding Equity Awards at Fiscal Year-End table in Coya Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Coya Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Howard BermanChief Executive Officer$1,317,200
David SnyderChief Financial Officer and Chief Operating Officer$947,888
Adrian Hepner · this pageFormer President, Chief Medical Officer$622,158
Fred GrossmanPresident, Chief Medical Officer$592,482

The full Coya Therapeutics compensation record

free company brief

This page is one person within Coya Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Coya Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Adrian Hepner's compensation dossier · One-time report. No refunds.